Recent trends and future perspectives in isolated hepatic perfusion in the treatment of liver tumors
β Scribed by Rothbarth, J ;Tollenaar, RAEM ;van de Velde, CJH
- Book ID
- 120503367
- Publisher
- Expert Reviews
- Year
- 2006
- Tongue
- English
- Weight
- 356 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1473-7140
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The annual rate of progression to cirrhosis in patients with chronic HBV is 0.4 to 14.2% and that of death 4 to 10%. HCC risk increases in parallel with the severity and duration of infection, with an annual incidence less than 0.5% in carriers and 6% in patients with cirrhosis. The mai
The prognosis of patients with irresectable liver metastases derived from colorectal cancer is invariably poor; unfortunately, these tumours show only minor responses to conventional anticancer agents. The best responses have been obtained by fluoropyrimidines delivered as continuous infusion into t